INTEGRA Biosciences’ pipettes help progress small molecule inhibitors from discovery to clinical trials

  • Post author:
  • Post category:uncategorized

RAPT Therapeutics in San Francisco, USA, relies on INTEGRA Biosciences’ pipettes to seamlessly accelerate the development of its candidate small molecule inhibitors for the treatment of inflammatory diseases and cancers.